IFI16 in Human Prostate Cancer

Increased expression of IFI16 protein (encoded by the IFI16 gene) in normal human prostate epithelial cells is associated with cellular senescence-associated cell growth arrest. Consistent with a role for IFI16 protein in cellular senescence, the expression of IFI16 protein is either very low or not detectable in human prostate cancer cell lines. We now report that treatment of DU-145 and LNCaP prostate cancer cell lines with histone deacetylase inhibitor trichostatin A (TSA) or CGK1026 resulted in transcriptional activation of the IFI16 gene. The induction of IFI16 protein in LNCaP cells was dependent on the duration of TSA treatment. Furthermore, TSA treatment of LNCaP cells up-regulated the expression of Janus-activated kinase 1 protein kinase and modulated the transcription of certain IFN-activatable genes. However, overexpression of exogenous Janus-activated kinase 1 protein in LNCaP cells and treatment of cells with IFNs (α and γ) did not increase the expression of IFI16. Instead, the transcriptional activation of IFI16 gene by TSA treatment of LNCaP cells was dependent on transcriptional activation by c-Jun/activator protein-1 transcription factor. Importantly, increased expression of IFI16 in LNCaP cells was associated with decreases in the expression of androgen receptor and apoptosis of cells. Conversely, knockdown of IFI16 expression in TSA-treated LNCaP cells increased androgen receptor protein levels with concomitant decreases in apoptosis. Together, our observations provide support for the idea that histone deacetylase–dependent transcriptional silencing of the IFI16 gene in prostate epithelial cells contributes to the development of prostate cancer. (Mol Cancer Res 2007;5(3):251–9)

[1]  J. Trapani,et al.  Transcription and Growth Regulatory Functions of the HIN-200 Family of Proteins , 1999, Molecular and Cellular Biology.

[2]  R. Johnstone,et al.  Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence , 2003, Oncogene.

[3]  D. Choubey,et al.  Interferon-inducible p202 in the susceptibility to systemic lupus. , 2002, Frontiers in bioscience : a journal and virtual library.

[4]  L. Mahadevan,et al.  Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun , 1994, Molecular and cellular biology.

[5]  F. Saatcioglu,et al.  Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells , 2005, The Prostate.

[6]  K. Bhakat,et al.  Regulation of the HumanO 6-Methylguanine-DNA Methyltransferase Gene by Transcriptional Coactivators cAMP Response Element-binding Protein-binding Protein and p300* , 2000, The Journal of Biological Chemistry.

[7]  R. Schreiber,et al.  IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression. , 2005, Cancer research.

[8]  E. Borden,et al.  Second-generation interferons for cancer: clinical targets. , 2000, Seminars in cancer biology.

[9]  S. D’Souza,et al.  p202 levels are negatively regulated by serum growth factors. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  Y. Lazebnik,et al.  Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE , 1994, Nature.

[11]  J. Trapani,et al.  Critical role of the transcription factor AP‐1 for the constitutive and interferon‐induced expression of IFI 16 , 2003, Journal of cellular biochemistry.

[12]  N. Fujiuchi,et al.  Requirement of IFI16 for the Maximal Activation of p53 Induced by Ionizing Radiation* , 2004, Journal of Biological Chemistry.

[13]  B. Aggarwal,et al.  Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines , 2001, Oncogene.

[14]  F. Alimirah,et al.  Androgen receptor auto‐regulates its expression by a negative feedback loop through upregulation of IFI16 protein , 2006, FEBS letters.

[15]  Karl G. Kohlgraf,et al.  Mechanisms of Cell Death Induced by Histone Deacetylase Inhibitors in Androgen Receptor–Positive Prostate Cancer Cells , 2006, Molecular Cancer Research.

[16]  C. Horvath,et al.  Unexpected roles for deacetylation in interferon- and cytokine-induced transcription. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[17]  P. Atadja,et al.  Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824 , 2005, Molecular Cancer Therapeutics.

[18]  Y. Ip,et al.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. , 1998, Current opinion in cell biology.

[19]  P. Lengyel,et al.  The interferon system. A bird's eye view of its biochemistry. , 1992, The Journal of biological chemistry.

[20]  D. Tindall,et al.  Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. , 2002, Cancer research.

[21]  Jun Qin,et al.  A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway , 2003, Oncogene.

[22]  R A Rifkind,et al.  Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. , 2000, Cancer research.

[23]  Hong Xin,et al.  DU‐145 and PC‐3 human prostate cancer cell lines express androgen receptor: Implications for the androgen receptor functions and regulation , 2006, FEBS letters.

[24]  J. Doly,et al.  Inhibition of Histone Deacetylation Induces Constitutive Derepression of the Beta Interferon Promoter and Confers Antiviral Activity , 2001, Journal of Virology.

[25]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[26]  Jaejoon Won,et al.  Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Ekström,et al.  The human histone deacetylase family. , 2001, Experimental cell research.

[28]  S. Hayward,et al.  Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  O. Pereira-smith,et al.  Role of IFI 16 in cellular senescence of human fibroblasts , 2004, Oncogene.

[30]  Ricky W Johnstone,et al.  Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? , 2003, Cancer cell.

[31]  William E. Stewart,et al.  The Interferon System , 1979, Springer Vienna.

[32]  Qing Yang,et al.  Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival , 2005, Cancer Cell International.

[33]  J. Trapani,et al.  Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16 , 2000, Oncogene.

[34]  R. Dahiya,et al.  Histone deacetylase and DNA methyltransferase in human prostate cancer. , 2001, Biochemical and biophysical research communications.

[35]  Y. Sowa,et al.  Trichostatin A activates the osteopontin gene promoter through AP1 site. , 2004, Biochemical and biophysical research communications.

[36]  C. Allis,et al.  Roles of histone acetyltransferases and deacetylases in gene regulation , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[37]  M. Campbell,et al.  Synergistic growth inhibition of prostate cancer cells by 1α,25 Dihydroxyvitamin D3 and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A† , 2001, Oncogene.

[38]  S. Drăghici,et al.  Epigenetic silencing of multiple interferon pathway genes after cellular immortalization , 2003, Oncogene.